Skip to main content
Markdown filings API. Get API access →
OICS v0.3.3 class · Healthcare

Commercial Biotech

ID CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.

01

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.
02

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies533 Listed with filings278
Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company Ticker Country Market cap Filings
STELLA PHARMA CORPORATION 4888 Japan — 321
JW (Cayman) Therapeutics Co. Ltd 2126 Cayman Islands — 296
Zhaoke Ophthalmology Limited 6622 Cayman Islands — 287
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 6990 Hong Kong — 269
AIM Vaccine Co., Ltd. 6660 Hong Kong — 255
Lepu Biopharma Co., Ltd. 2157 Hong Kong — 250
Pelthos Therapeutics Inc. PTHS United States of America $88.80M 250
Enimmune corporation 6564 Taiwan — 246
Clover Biopharmaceuticals, Ltd. 2197 Hong Kong — 231
CANbridge Pharmaceuticals Inc. 1228 Cayman Islands — 227
Keymed Biosciences Inc. 2162 Cayman Islands — 208
Cutia Therapeutics 2487 Hong Kong — 195
TECNOVAX S.A. — Argentina — 182
StemCyte International Ltd. 4178 Taiwan — 174
Onconic Therapeutics Inc. 476060 South Korea — 171
3D Medicines Inc. 1244 Hong Kong — 167
Sunshine Lake Pharma Co., Ltd. 6887 Hong Kong — 119
Merdury Biopharmaceutical Corporation 6932 Taiwan — 92
Ab&B Bio-Tech CO., LTD. JS 2627 Hong Kong — 78
Shanghai Bao Pharmaceuticals Co., Ltd. 2659 Hong Kong — 74
Xuanzhu Biopharmaceutical Co., Ltd. 2575 Hong Kong — 73
Vigonvita Life Sciences Co., Ltd. 2630 Hong Kong — 72
ZHUHAI TRINOMAB PHARMACEUTICAL CO., LTD. 688806 China — 58
Indivior Pharmaceuticals, Inc. — United States of America — 56
IMPACT Therapeutics, Inc. — China — 48
Alebund Pharmaceuticals (Jiangsu) Limited — China — 35
Jiangxi Institute of Biological Products Inc. — China — 26
Trevena Inc TRVN United States of America — 3

Companies in Biotechnology → Open in the screener →

03

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

No aliases listed.

Not here
Sent here from
04

Other classes in Biotechnology

Clinical-Stage Biotech CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Also preclinical, drug developer

05

Permanent link

https://financialfilings.com/oics/CMB/

This page is keyed by the class ID CMB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard